IPHA logo

Innate Pharma SA (IPHA)

Profile

Full Name

Innate Pharma S.A.

Ticker Symbol

IPHA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

October 17, 2019

Indexes

Not included

Website

http://www.innate-pharma.com

Employees

181

Key Details

Price

$1.97(+1.55%)

Market cap

$165.11M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$13.67M(-75.67% YoY)

Annual EPS

-$0.66(-577.82% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.97
IPHA price is $1.97

30-Day Relative Volume

0.19
IPHA 30-day relative volume is 0.19

Price Performance

Price Most recent change

+1.55%
IPHA price was up +1.55% on Apr 17, 2025

Price YTD change

+7.07%
IPHA price is up +7.07% since January 1st

Price 1-year change

-18.26%
IPHA price is down -18.26% year-on-year

Price 3-year change

-37.06%
IPHA price is down -37.06% over the past 3 years

Price Range

Price All-time high

$11.95
IPHA price is currently -83.51% below its historical high of $11.95

Price 3-year low

$1.29
IPHA price is currently +52.71% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$165.11M
IPHA market capitalization is $165.11 million

Market cap 3-year change

-33.82%
IPHA market capitalization is down -33.82% over the past 3 years

Market cap All-time high

$646.81M
IPHA market capitalization is currently -74.47% below its historical high of $646.81 million

Market cap sector rank

54.61%
IPHA market capitalization is higher than 54.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.67%
IPHA shares outstanding is up +3.67% year-on-year

Shares Outstanding 3-Year Change

+5.15%
IPHA shares outstanding is up +5.15% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.26
IPHA beta is 0.26

200-day SMA

$2.00
IPHA price is currently -1.65% below its 200-day simple moving average

50-day SMA

$2.00
IPHA price is currently -1.46% below its 50-day simple moving average

RSI

53.30
IPHA 14-day relative strength index is 53.30

Volume

0.19
IPHA 30-day relative volume is 0.19

ATR

$0.13
IPHA average true range is $0.13

10-day Historical Volatility

53.62%
IPHA 10-day historical volatility is 53.62%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$13.67M
IPHA annual revenue is $13.67 million

Revenue Analysts estimate

$98.47M
IPHA annual revenue is currently -86.11% lower than the consensus analysts' forecast

Revenue 1-year change

-75.67%
IPHA annual revenue is down -75.67% year-on-year

Revenue Sector rank

31.58%
IPHA annual revenue is higher than 31.58% of companies in Healthcare sector

EPS

EPS

-$0.66
IPHA annual earnings per share is -$0.66

EPS Analysts estimate

-
IPHA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-577.82%
IPHA annual earnings per share is down -577.82% year-on-year

EPS Sector rank

64.05%
IPHA annual earnings per share is higher than 64.05% of companies in Healthcare sector

Profit

Gross profit

-
IPHA annual gross profit value is unknown

Gross margin

-
IPHA annual gross profit margin value is unknown

Operating profit

-$55.82M
IPHA annual operating income is -$55.82 million

Operating margin

-408.26%
IPHA annual operating profit margin is -408.26%

Net income

-$53.54M
IPHA annual net profit is -$53.54 million

Net margin

-391.60%
IPHA annual net profit margin is -391.60%

Expenses

Total expenses

$69.50M
IPHA annual total expenses is $69.50 million

Operating expenses

$69.50M
IPHA annual total operating expenses is $69.50 million

Cost of goods sold

-
IPHA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$21.34M
IPHA annual SGA is $21.34 million

Depreciation and amortization

$2.16M
IPHA annual depreciation & amortization is $2.16 million

Interest expense

$4.30M
IPHA annual interest expense is $4.30 million

Income tax

$0.00
IPHA annual income tax is $0.00

EBIT & EBITDA

EBIT

-$49.24M
IPHA annual earnings before interest & taxes is -$49.24 million

EBITDA

-$47.08M
IPHA annual EBITDA is -$47.08 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$115.56M
IPHA annual total assets is $115.56 million

Non current assets

$26.34M
IPHA annual long term assets is $26.34 million

Current assets

$89.22M
IPHA annual total current assets is $89.22 million

Cash and cash equivalents

$69.09M
IPHA annual cash & cash equivalents is $69.09 million

Accounts receivable

$5.17M
IPHA annual accounts receivable is $5.17 million

Inventory

-
IPHA annual inventory value is unknown

Liabilities

Total liabilities

$106.37M
IPHA annual total liabilities is $106.37 million

Long term liabilities

$72.05M
IPHA annual total long term liabilities is $72.05 million

Current liabilities

$34.32M
IPHA annual total current liabilities is $34.32 million

Accounts payable

$16.66M
IPHA annual accounts payable is $16.66 million

Debt

Total debt

$32.25M
IPHA annual total debt is $32.25 million

Total debt 1-year change

-26.86%
IPHA annual total debt is down -26.86% year-on-year

Long term debt

$23.19M
IPHA annual long term debt is $23.19 million

Short term debt

$9.06M
IPHA annual short term debt is $9.06 million

Equity & Capital

Shareholders equity

$9.19M
IPHA annual stockholders equity is $9.19 million

Book value

$9.19M
IPHA annual book value is $9.19 million

Retained earnings

-$402.04M
IPHA annual retained earnings is -$402.04 million

Working capital

$54.90M
IPHA annual working capital is $54.90 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$7.46M
IPHA annual cash flow from operations is -$7.46 million

Cash from operations 1-year change

+78.82%
IPHA annual cash flow from operations is up +78.82% year-on-year

Cash from investing

$9.96M
IPHA annual cash flow from investing activities is $9.96 million

Cash from investing 1-year change

-55.42%
IPHA annual cash flow from investing activities is down -55.42% year-on-year

Cash from financing

-$6.50M
IPHA annual cash flow from financing activities is -$6.50 million

Cash from financing 1-year change

-205.53%
IPHA annual cash flow from financing activities is down -205.53% year-on-year

CAPEX

CAPEX

$423.20K
IPHA annual capital expenditures is $423.20 thousand

CAPEX 1-year change

-83.37%
IPHA annual capital expenditures is down -83.37% year-on-year

Free Cash Flow

Free cash flow

-$7.89M
IPHA annual free cash flow is -$7.89 million

Free cash flow 1-year change

+79.13%
IPHA annual free cash flow is up +79.13% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
IPHA annual gross profit margin value is unknown

Operating margin

-408.26%
IPHA annual operating profit margin is -408.26%

Net margin

-391.60%
IPHA annual net profit margin is -391.60%

ROA & ROE

ROA

-33.55%
IPHA annual return on assets is -33.55%

ROE

-160.88%
IPHA annual return on equity is -160.88%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IPHA price to earnings ratio value is unknown

PE ratio Sector rank

-
IPHA price to earnings ratio is unknown

PB Ratio

PB ratio

17.96
IPHA price to book ratio is 17.96

PB ratio Sector rank

96.46%
IPHA price to book ratio is higher than 96.46% of companies in Healthcare sector

PS Ratio

PS ratio

-
IPHA price to sales ratio value is unknown

PS ratio Sector rank

-
IPHA price to sales ratio is unknown

Enterprise value

Enterprise value

$128.27M
IPHA enterprise value is $128.27 million

Enterprise value Sector rank

52.77%
IPHA enterprise value is higher than 52.77% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
IPHA EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
IPHA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.60
IPHA annual current ratio is 2.60

Quick ratio

-
IPHA annual quick ratio value is unknown

Leverage

Debt to equity

3.51
IPHA annual debt to equity ratio is 3.51

Interest coverage ratio

-11.45
IPHA annual interest coverage ratio is -11.45

Risk & Stability

Piotroski F-Score

-
IPHA piotroski f-score value is unknown

Altman Z-Score

-4.66
IPHA altman z-score is -4.66

Analyst ratings

Recent major analysts updates

Mar 28, 25 HC Wainwright & Co.
Buy
Feb 6, 25 HC Wainwright & Co.
Buy
Jan 17, 25 HC Wainwright & Co.
Buy
Dec 9, 24 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Sep 13, 24 HC Wainwright & Co.
Buy
Jun 12, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Apr 11, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Aardvark Therapeutics (AARD)
INBX logo
Inhibrx Biosciences (INBX)
LNSR logo
LENSAR (LNSR)
RZLT logo
Rezolute (RZLT)
PROC logo
Procaps Group SA (PROC)
CVRX logo
CVRx (CVRX)
INMB logo
INmune Bio (INMB)
MASS logo
908 Devices (MASS)
ANNX logo
Annexon (ANNX)
  • What is the ticker symbol for Innate Pharma SA?
  • Does Innate Pharma SA pay dividends?
  • What sector is Innate Pharma SA in?
  • What industry is Innate Pharma SA in?
  • What country is Innate Pharma SA based in?
  • When did Innate Pharma SA go public?
  • Is Innate Pharma SA in the S&P 500?
  • Is Innate Pharma SA in the NASDAQ 100?
  • Is Innate Pharma SA in the Dow Jones?
  • When was Innate Pharma SA's last earnings report?
  • When does Innate Pharma SA report earnings?

What is the ticker symbol for Innate Pharma SA?

The ticker symbol for Innate Pharma SA is NASDAQ:IPHA

Does Innate Pharma SA pay dividends?

No, Innate Pharma SA does not pay dividends

What sector is Innate Pharma SA in?

Innate Pharma SA is in the Healthcare sector

What industry is Innate Pharma SA in?

Innate Pharma SA is in the Biotechnology industry

What country is Innate Pharma SA based in?

Innate Pharma SA is headquartered in France

When did Innate Pharma SA go public?

Innate Pharma SA's initial public offering (IPO) was on October 17, 2019

Is Innate Pharma SA in the S&P 500?

No, Innate Pharma SA is not included in the S&P 500 index

Is Innate Pharma SA in the NASDAQ 100?

No, Innate Pharma SA is not included in the NASDAQ 100 index

Is Innate Pharma SA in the Dow Jones?

No, Innate Pharma SA is not included in the Dow Jones index

When was Innate Pharma SA's last earnings report?

Innate Pharma SA's most recent earnings report was on Mar 27, 2025

When does Innate Pharma SA report earnings?

The next expected earnings date for Innate Pharma SA is May 13, 2025
On this page